Cleaning Method Validation for Estimation of Dipyridamole Residue on the Surface of Drug Product Manufacturing Equipment Using Swab Sampling and by High Performance Liquid Chromatographic Technique
Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2020, Vol 17, Issue 2
Abstract
Objectives: Cleaning validation is the procedure used to ensure that the cleaning process has eliminated the residues of drug substance from on the equipment surface after manufacture. A simple, sensitive, robust, and accurate high performance liquid chromatographic method was developed for the quantitative estimation of dipyridamole in swab samples obtained from the equipment surface after the manufacture of dipyridamole modified release capsules. Materials and Methods: The method was developed by using a Hypersil BDS C18 (150×4.6 mm, 5 μm) column with mobile phase containing a mixture of buffer (potassium dihydrogen phosphate buffer, pH 7.0±0.05) and methanol in the ratio of 30:70 v/v. Flow rate was 1.5 mL/min, column temperature was 45°C, and injection volume was 5 μL. Results: The method was validated and a specificity study was conducted to prove that there was no interference from blank and swab blank at the retention time of dipyridamole. The limit of detection and limit of quantification (LOQ) were established by using a series of linearity solutions and were found to be 0.041 μg/mL and 0.124 μg/mL, respectively. The method precision at the LOQ level was 8.6% relative standard deviation (RSD), method precision was 0.2% RSD, and ruggedness was 0.3% RSD. The method was accurate from the concentration of 0.13 μg/mL to 21.80 μg/mL and the recovery results met the acceptance criteria. The linearity of the method was found from 0.12 μg/mL to 20.14 μg/mL and the r2 value was 0.997. The robustness for the flow rate, wavelength, column temperature, buffer pH, and mobile phase ratio variations was tested, and all the system suitability parameters were met. Conclusion: The method validation was performed as per the regulatory requirements and guidelines. The validation parameters met the acceptance criteria and the proposed method can be applied for the intended routine swab analysis.
Authors and Affiliations
Sriram VALAVALA, Nareshvarma SEELAM, Subbaiah TONDEPU, Vivekanandan SUNDARAMURTHY
Keywords
Related Articles
- EP ID EP684747
- DOI 10.4274/tjps.galenos.2019.70446
- Views 172
- Downloads 0
Comparative In Vitro and In Vivo Evaluation of Fenofibric Acid as an Antihyperlipidemic Drug
Objectives: Fenofibric acid (FA) is antihyperlipidemic agent and commercially available as a tablet formulation that weighs 840 mg for 105 mg of active substance. A new formulation with less inactive substance was develo...
In Vivo Antioxidant Activity of Different Fractions of Indigofera Barberi Against Paracetamol-induced Toxicity in Rats
Objectives: To evaluate the in vivo antioxidant activity of chloroform extract fractions of Indigofera barberi (whole plant) against paracetamol-induced toxicity in rats. Materials and Methods: For 7 days, rats were tre...
Microwave-assisted Preparation of Cross-linked Gelatin-Paracetamol Matrices: Optimization Using the D-optimal Design
Objectives: This study was conducted to assess the effect of microwave heating on the preparation of paracetamol cross-linked gelatin matrices by using the design of experiment (DoE) approach and explore the influence of...
Simultaneous Determination of Hydrochlorothiazide and Irbesartan from Pharmaceutical Dosage Forms with RP-HPLC
Objectives: In this work, a simple and rapid liquid chromatographic method for the simultaneous determination of irbesartan (IRBE) and hydrochlorothiazide (HCT) was developed and validated by reverse phase high performan...
Deposition Pattern of Polydisperse Dry Powders in Andersen Cascade Impactor - Aerodynamic Assessment for Inhalation Experimentally and In Silico
Objectives: An impactor is a standard instrument that applied for particle deposition assessment in the pharmaceutical aerosols. It provides data comparison between inhaler formulations. However, the deposition pattern i...